
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Historical Deciles for [ALNY] Alnylam Pharmaceuticals Inc
Data updated 2024-Nov-01 (Friday)Compare current performance/technical metrics to history for Alnylam Pharmaceuticals Inc. Range of values presented below in deciles puts current values into historical context (Up to 5-years)
Provided As-is for informational/educational purposes only and should not be construed as investment advice . Past performance may not be not indicative of future results. Always consult your Investment Adviser before any decision
Share
Use widget to view Historical Metric Deciles for other Stocks/ETFs/Indices
Summary 2024-Nov-01 Friday
Day Change | +2.75% Top | Day Volatility | 3.80% Mid |
Streak | ↑ 1 day Mid | % Streak | +2.75% Mid |
RSI | 44 Low | CCI | -105.9 Low |
MACD | -2.94 Low | ATR | 8.16 Mid |
ADX | 23.5 Mid | SSO | 24.0 Low |
Change | Volatility | % off SMA | |
---|---|---|---|
5-day | -3.84% Low | 10.35% Mid | -1.73% Low |
10-day | -7.44% Low | 14.19% Mid | -4.08% Low |
20-day | +2.21% Mid | 15.45% Mid | -3.74% Low |
50-day | -1.23% Mid | 24.30% Low | -0.33% Mid |
100-day | +75.10% Top | 99.86% Top | +6.37% Mid |
200-day | +47.30% Mid | 114.39% Top | +32.80% Top |
Choose Metric type
Select Performance timeframe above to analyze
On 2024-Nov-01, Alnylam Pharmaceuticals Inc had:daily change of +2.75% intraday volatility of 3.8% 1 ↑(up) day streak yielding +2.75% See how this compares to historical ranges below. Upto last 5 years are bucketed into deciles (click on chart line for details) with 2024-Nov-01 value annotated for comparison
Related to Alnylam Pharmaceuticals Inc
Information for Alnylam Pharmaceuticals Inc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets Currently Viewing
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-14 on Google
SEC Reports : Quarterly reports around 2025-May-14 on SEC Edgar
Compare Alnylam Pharmaceuticals Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Alnylam Pharmaceuticals Inc
Industry : Biotechnology industry performance which includes Alnylam Pharmaceuticals Inc